Johanna Hultgren

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Part of Essent Netwerk Facilities Zuid BV, Edon is a Dutch company that provides electric services. The company is based in Zwolle, the Netherlands. Edon was acquired by Essent Netwerk Facilities Zuid BV on January 01, 1999.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.

Part of Merck & Co., Inc., Merck Sharp & Dohme (Sweden) AB is a biopharmaceutical company based in Stockholm, Sweden. MSD Sweden is focused on inventing medicines and vaccines to save and improve lives, sharing a vision and mission to achieve this goal. The Swedish company was founded in 1974. The CEO is Björn Fredrik Niklas Andreasson.

Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden.

TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018.

Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease.

MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden.

Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015.

Part of XNK Therapeutics AB, CellProtect Nordic Pharmaceuticals AB is a clinical-stage biotechnology company based in Huddinge, SE. CellProtect Nordic Pharmaceuticals is one of the pioneering companies in the field of cell therapy, developing unique and individualized natural killer (NK) cell-based cancer therapies. The Swedish company has built a tailor-made GMP clean room facility for manufacturing clinical products and is currently evaluating its lead product, evencaleucel, in a randomized, controlled, phase II study for the treatment of multiple myeloma. The company was founded in 2012 and the CEO is Johan Liwing.

Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.

Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology.

Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom.

UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields.

Texray AB engages in development of medical technology products. It offers radiation protective textile. The company was founded by Petra Apell and Fredrik Gellerstedt and is headquartered in Göteborg, Sweden.

Iscaff Pharma AB develops platform and drugs for treatment of cancer. It develops a scaffold technology for drug development and treatment of cancer. The firm's products and services include development support; 3D printed scaffolds; licensing of technologies; and diagnostics. The company was founded by Göran Landberg and Anders Torbjörn Ståhlberg and is headquartered in Gothenburg, Sweden.

Transmed Gothenburg AB provides scientific and technical research and development services. The company is based in Gothenburg, Sweden.

XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden.

Simplexia AB is a company based in Gothenburg, Sweden that aims to launch the first vaccine for the treatment and prevention of genital herpes. The Swedish company is driven by the goal to curtail and treat infection with herpes simplex virus (HSV), one of the world's most prevalent sexually transmitted diseases. The team at Simplexia is composed of experts in pharmaceutical development, including Prof. Jan-Åke Liljeqvist and the Department of Virology at the Sahlgrenska Academy. The vaccine is based on research that showed glycoproteins from HSV-1 and 2, when administered as a vaccine, are highly immunogenic and provide protection in mouse models.

SiMSen Diagnostics AB develops diagnostic substances. The company is based in Gothenburg, Sweden.